CNR1 and cardiac hypertrophy: Of note, though the majority of the literature agrees that CB1 antagonists confer an anti-hypertrophic property, the CB1/CB2 dual agonist CB-13 inhibited both myocyte enlargement and fetal gene expression [38], indicating that CB1 protects against cardiac hypertrophy, which is in contrast to the majority of reports.